Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Clostridium perfringens epsilon-toxin × Plasma cell × 30 days × Clear all

Sponsor

Cancer Type

Interventions

Dexamethasone 62 Lenalidomide 37 daratumumab 36 Bortezomib 30 Cyclophosphamide 25 pomalidomide 23 Calcium Dobesilate 22 carfilzomib 19 Biopsy 19 Specimen Handling 18 Magnetic Resonance Spectroscopy 16 talquetamab 14 fludarabine 14 dexamethasone acetate 11 dexamethasone 21-phosphate 11 auricularum 11 iberdomide 9 selinexor 8 isatuximab 7 trametinib 6 fludarabine phosphate 6 belantamab mafodotin 5 venetoclax 4 tocilizumab 4 dabrafenib 4 X-Rays 4 Whole-Body Irradiation 4 nirogacestat 3 elotuzumab 3 Sunitinib 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡